Nuclear Magnetic Resonance and Magnetization Studies of the Ferromagnetic Ordering Temperature Suppression in Ru Deficient SrRuO3

The synthesis of SrRuO3 under high-pressure oxygen produces a nonstoichiometric form with randomly distributed vacancies on the Ru-sites, along with a significantly reduced ferromagnetic ordering temperature. In order to gain additional insight into the suppression of the ferromagnetism, local studies utilizing 99,101 Ru zero-field spin-echo NMR, and Ru K-edge XAFS, along with complimentary magnetization and x-ray diffraction measurements, have been carried out on samples of SrRuO3 annealed at both ("ambient") atmospheric pressure and "high-pressure" oxygen (600 atm). Consistent with previous work, the NMR spectrum for "ambient" SrRuO3 consists of two well-defined peaks at 64.4 MHz and 72.2 MHz corresponding to the 99Ru and 101Ru isotopes, respectively, and a hyperfine field of 329 kG. Although the magnetization measurements show a lower ferromagnetic ordering temperature for the "high-pressure" oxygen sample (90 K compared to 160 K for the "ambient" sample), the NMR spectrum shows no significant shift in the two peak frequencies. However, the two peaks exhibit considerable broadening, along with structure on both the low and high frequency sides which is believed to be quadrupolar in origin. Analysis of the Ru K-edge XAFS reveals more disorder in the Ru-O bond for the "high-pressure" oxygen sample compared to the "ambient" sample. Furthermore, XANES of Ru K-edge analysis indicates no difference in the valence of Ru between the two samples. The magnetic behavior indicates the existence of some vacancies on the Ru sites for the "high-pressure" oxygen sample.Comment: Proceedings of the 3rd Polish-US Workshop on Magnetism and Superconductivity of Advanced Materials, July 14-19, 2002, Ladek Zdroj (Poland), to appear in Physica

Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report

Severe mucocutaneous (MCL) and diffuse (DCL) forms of American cutaneous leishmaniasis (ACL) are infrequent in Venezuela. Chemotherapy produces only transitory remission in DCL, and occasional treatment failures are observed in MCL. We have evaluated therapy with an experimental vaccine in patients with severe leishmaniasis. Four patients with MCL and 3 with early DCL were treated with monthly intradermal injections of a vaccine containing promastigotes of Leishmania (Viannia) braziliensis killed by pasteurization and viable Bacillus Calmette- Guerin. Clinical and immunological responses were evaluated. Integrity of protein constituents in extracts of pasteurized promastigotes was evaluated by gel electrophoresis. Complete remission of lesions occurred after 5-9 injections in patients with MCL or 7-10 injections in patients with early DCL. DCL patients developed positive skin reactions, average size 18.7 mm. All have been free of active lesions for at least 10 months. Adverse effects of the vaccine were limited to local reactivity to BCG at the injection sites and fever in 2 patients. Extracts of pasteurized and fresh promastigotes did not reveal differences in the integrity of protein components detectable by gel electrophoresis. Immunotherapy with this modified vaccine offers an effective, safe option for the treatment of patients who do not respond to immunotherapy with vaccine containing autoclaved parasites or to chemotherapy